Corporate Tech Investors

Alexion Pharmaceuticals

Alexion Pharmaceuticals is a corporate venture capital group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our first commercial product is Soliris® (eculizumab), the world's first and only approved terminal complement inhibitor.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/6/2015

Transaction History

Our records indicate that Alexion Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Ludwig Hantson

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Alexion Pharmaceuticals has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Alexandria Venture Investments | Alfa Laval

Share this article

About Our Corporate VC Database

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary